New York State Common Retirement Fund Harpoon Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.78 - $5.02 $10,001 - $28,207	-5,619 Reduced 97.3%	156 $0
Q4 2021 Feb 02, 2022	SELL	$5.69 - $7.83 $193 - $266	-34 Reduced 0.59%	5,775 $44,000
Q3 2021 Nov 02, 2021	SELL	$7.88 - $14.0 $90,793 - $161,308	-11,522 Reduced 66.48%	5,809 $46,000
Q2 2021 Aug 02, 2021	BUY	$13.81 - $23.25 $94,073 - $158,379	6,812 Added 64.76%	17,331 $240,000
Q2 2020 Aug 07, 2020	BUY	$11.11 - $24.72 $62,216 - $138,432	5,600 Added 113.84%	10,519 $175,000
Q3 2019 Nov 07, 2019	BUY	$10.93 - $17.47 $48,299 - $77,199	4,419 Added 883.8%	4,919 $67,000
Q2 2019 Aug 09, 2019	BUY	$10.0 - $13.03 $5,000 - $6,515	500 New	500 $7,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.